Making glioblastoma more vulnerable to treatment

byMedical College of Georgia at Augusta UniversityDr. Waaqo Daddacha. Credit: Michael Holahan, Augusta UniversityIn the tough war against glioblastoma, scientists are taking a cue from viruses o

Updated on: January 04,2024

Making glioblastoma more vulnerable to treatment

byMedical College of Georgia at Augusta UniversityDr. Waaqo Daddacha. Credit: Michael Holahan, Augusta UniversityIn the tough war against glioblastoma, scientists are taking a cue from viruses o

Updated on:January 04,2024

How does obesity cause cancer?

Overweight and obesity is the second biggest cause of cancer in the UK – causing more than 1 in 20 cancer cases.The risk is higher the more overweight you are and the longer you are overweight for.Kee

Updated on: December 19,2023

How does obesity cause cancer?

Overweight and obesity is the second biggest cause of cancer in the UK – causing more than 1 in 20 cancer cases.The risk is higher the more overweight you are and the longer you are overweight for.Kee

Updated on:December 19,2023

New optimism on myelodysplastic syndromes

by Sylvester Comprehensive Cancer CenterCredit: Pixabay/CC0 Public DomainPhysician scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have publish

Updated on: December 22,2023

New optimism on myelodysplastic syndromes

by Sylvester Comprehensive Cancer CenterCredit: Pixabay/CC0 Public DomainPhysician scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have publish

Updated on:December 22,2023

What you should know about thyroid cancer in adolescents, young adults

by Deb BalzerCredit: Pixabay/CC0 Public DomainCancer is often thought of as a disease that affects older people, and with the median age of a cancer diagnosis at 66 years, it does. But cancer can be d

Updated on: December 23,2023

What you should know about thyroid cancer in adolescents, young adults

by Deb BalzerCredit: Pixabay/CC0 Public DomainCancer is often thought of as a disease that affects older people, and with the median age of a cancer diagnosis at 66 years, it does. But cancer can be d

Updated on:December 23,2023

Scan based on lizard saliva detects rare tumor

by Jared Sagoff,Radboud UniversityThis is a cross-sectional view of the torso. The gray areas show the anatomy based on the CT scan, while the colored sections represent the radioactive signal m

Updated on: October 31,2024

Scan based on lizard saliva detects rare tumor

by Jared Sagoff,Radboud UniversityThis is a cross-sectional view of the torso. The gray areas show the anatomy based on the CT scan, while the colored sections represent the radioactive signal m

Updated on:October 31,2024

Toxicity data reveal no safety concerns with S/N1806 bladder cancer trial

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainUpdated toxicity data from the ongoing SWOG/NRG 1806 clinical trial, which tests combining chemoradiation therapy with immunotherapy in

Updated on: December 20,2023

Toxicity data reveal no safety concerns with S/N1806 bladder cancer trial

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainUpdated toxicity data from the ongoing SWOG/NRG 1806 clinical trial, which tests combining chemoradiation therapy with immunotherapy in

Updated on:December 20,2023

Genetic analysis of the most common type of bladder cancer yields guidance on treatment options

byUNC Lineberger Comprehensive Cancer CenterUC-GENOME study design and molecular subtyping shows enrichment of Stroma-rich primary tumors in metastatic datasets. Credit:Nature Communicatio

Updated on: December 21,2023

Genetic analysis of the most common type of bladder cancer yields guidance on treatment options

byUNC Lineberger Comprehensive Cancer CenterUC-GENOME study design and molecular subtyping shows enrichment of Stroma-rich primary tumors in metastatic datasets. Credit:Nature Communicatio

Updated on:December 21,2023

Researchers identify new genetic risk factors for persistent HPV infections

byUniversity of Maryland School of MedicineDistribution of binding affinity IC50 values by HLA-DRB1 allele category (A) all binding predictions (B) Excluding non-binders (lC50 > 5000 nM). Cre

Updated on: April 27,2024

Researchers identify new genetic risk factors for persistent HPV infections

byUniversity of Maryland School of MedicineDistribution of binding affinity IC50 values by HLA-DRB1 allele category (A) all binding predictions (B) Excluding non-binders (lC50 > 5000 nM). Cre

Updated on:April 27,2024

First test of anti-cancer agent PAC-1 in human clinical trials shows promise

by Diana Yates,University of Illinois at Urbana-ChampaignProcaspase-3 (PC-3) expressions in diverse tumor histologies categorized as moderate-to-strong immunostaining intensities. Credit:B

Updated on: December 27,2023

First test of anti-cancer agent PAC-1 in human clinical trials shows promise

by Diana Yates,University of Illinois at Urbana-ChampaignProcaspase-3 (PC-3) expressions in diverse tumor histologies categorized as moderate-to-strong immunostaining intensities. Credit:B

Updated on:December 27,2023

Survival is a mixed matter for deadliest of pancreatic cancers

byUniversity of California - San DiegoPancreatic cancer cells (nuclei in blue) are shown growing as a sphere encased in membranes (red). Credit: National Cancer InstitutePancreatic ductal adenoc

Updated on: December 21,2023

Survival is a mixed matter for deadliest of pancreatic cancers

byUniversity of California - San DiegoPancreatic cancer cells (nuclei in blue) are shown growing as a sphere encased in membranes (red). Credit: National Cancer InstitutePancreatic ductal adenoc

Updated on:December 21,2023

Shorter MRI exam effectively detects cancer in dense breasts

Updated on: June 15,2025

Shorter MRI exam effectively detects cancer in dense breasts

Updated on:June 15,2025

Adjuvant Nivolumab Receives CHMP Recommendation for Completely Resected Stage IIB/C Melanoma

July 21, 2023Chris RyanThe European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended approval of nivolumab monotherapy for the adjuvant treatment of patients at least

Updated on: October 15,2023

Adjuvant Nivolumab Receives CHMP Recommendation for Completely Resected Stage IIB/C Melanoma

July 21, 2023Chris RyanThe European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended approval of nivolumab monotherapy for the adjuvant treatment of patients at least

Updated on:October 15,2023